CR Bard

Murray, United States Founded: 1907 • Age: 119 yrs Listed Acquired By Becton Dickinson
Products for vascular, urology, oncology, and surgical specialties

About CR Bard

CR Bard is a company based in Murray (United States) founded in 1907 was acquired by Becton Dickinson in April 2017. The company has 125 employees. CR Bard has completed 17 acquisitions, including Amertek Medical, Angiomed and ClearStream.

Key Metrics
  • Annual Revenue
    ₹264 Cr

    FY 2023 · +32% YoY

  • Net Profit
    ₹5.51 Cr

    FY 2023 · 2% margin

  • EBITDA
    ₹9.98 Cr

    FY 2023 · 4% margin

  • Investors
  • Employee Count
    125
  • Investments & Acquisitions
  • Acquired by

Apps and channels of CR Bard

its YouTube channel BD has 33.8K subscribers and 30 videos.

BD
YouTube 33.8K subscribers 30 videos Science & Technology
Open channel

Videos from CR Bard

The most watched videos on CR Bard's YouTube channel, BD (33.8K subscribers). Click a video to play it here.

Listen to Dr. Jeff Andrews talk about extended genotyping and cervical cancer screening
25.1K views
A clinician speaks about the impact testing for vaginitis has on her patients
5.3K views
Kylee Johnson, CNM, WHNP-BC talks about HPV self-collection in a healthcare setting
4.9K views
BD Nexiva™ Single Port Closed IV Catheter Insertion Techniques
4.2K views

More on BD.

Investors in CR Bard

CR Bard has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BD.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
BD is recognized for providing innovative medical technology solutions.
1897bd.comFranklin Lakes, United States
Premium access

Investor details for CR Bard

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Bard India Healthcare Private Limited (CR Bard)

Bard India Healthcare Private Limited is the primary company behind CR Bard. The board of Bard India Healthcare Private Limited currently have 4 directors; the longest-serving is Puay Lian Geraldine Lim, appointed in 2021. 17 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Puay Lian Geraldine Lim
DIN 09205273
Director01 Jul 20215 yrs 3 moBard India Healthcare Private Limited
Deepak Malhotra
DIN 09537624
Director22 Mar 20224 yrs 6 moBard India Healthcare Private Limited
Atul Grover
DIN 05320202
Director17 Jan 20233 yrs 8 moBard India Healthcare Private Limited
Ulrich Stefer
DIN 07447177
Director07 Apr 20251 yr 6 moBard India Healthcare Private Limited

People of CR Bard

946 people are tracked at CR Bard (406 in leadership, 13 in board & advisors, 527 in team); the tracked headcount is 125.

NameRoleGroup
Meera Gopalakrishnan
SVP & Global CMOLeadership
Jennifer Sipple
Vp, Global Marketing, Medication Management SolutionsLeadership
Manish Ladha
Gm, Software Technology Solutions And Senior Director Of Product ManagementLeadership
Bridget DeLano
Senior Art DirectorLeadership
Lisa Perronne
Senior Director, Division Quality Management, UCCLeadership
Iván Lugo
Vice President APM Global QualityLeadership
Heidi Casaletto
Vp/gm, Global Platform Leader For MicrobiologyLeadership
Kathryn Kelly
VP Of Digital Marketing And Commercial DataLeadership
Kathy Sullivan
VP, Commercial Effectiveness & Marketing OperationsLeadership
Christopher Mogen (C)
Digital Art DirectorLeadership
Wade M.
Associate Director Of Technology And EngineeringLeadership
Steve Gundersen
VP & GM, SCGLeadership
Ankush Rao
Director, Quality ManagementLeadership
Matthew Buraczenski
Director Of Product Security - Secure Technology SolutionsLeadership
Sajid Kunnummal
SVP & Chief Procurement OfficerLeadership
Penny Collins
Vp, Human ResourcesLeadership
Travis Gumbs
Sr. Director Of Microbiology Manufacturing OperationsLeadership
Michael Feld
Executive Vice President, Chief Revenue Officer and President, Life Sciences SegmentLeadership
Jessica Cates Fox
Vp, HR Specimen ManagementLeadership
Eric Smith
National Sales DirectorLeadership

926 more people are available in the full profile.

Premium access

Complete people profiles for CR Bard

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of CR Bard

Figures of Bard India Healthcare Private Limited, the primary company behind CR Bard, for FY 2023. Revenue was ₹264 Cr (+32% year on year). Net profit was ₹5.51 Cr (2% margin). EBITDA was ₹9.98 Cr (4% margin). Revenue has grown at a compounded annual rate of +31% over three years and +10% over five years.

  • ₹264 CrRevenue · FY 2023 · +32% YoY
  • ₹5.51 CrNet profit · 2% margin
  • ₹9.98 CrEBITDA · 4% margin
  • ₹90.4 LakhPaid-up capital
  • 125Employees (provident fund records)
  • +31%Revenue CAGR, 3 years
  • +10%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bard India Healthcare Private Limited are on its company page.

Premium access

Detailed financial statements for CR Bard

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CR Bard

CR Bard has strategically engaged in corporate development activities, having acquired 17 companies. Notable acquisitions include Amertek Medical, Angiomed and ClearStream.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Absorbable surgical sealants and hemostats are developed for leakage prevention.
life-bond.comCaesarea, Israel2007Jan 2020••••
Urine is captured non-invasively from incontinent adult females.
purewick.comSpring Valley, United States2012Jun 2017$30M
A vascular embolization device is developed for peripheral procedures.
embomedical.comGalway, Ireland2012Dec 2015$21M
Medical and surgical supplies are distributed in the United States.
liberatormedical.comStuart, United States1906Nov 2015$181M
Guidewire for Peripheral vascular line insertion
vascularpathways.comNaples, United States2005Jun 2014••••
PVC-free and latex-free urinary continence and urine drainage care products for the home and acute care markets
rocm.comStewartville, United States1988Sep 2013$262M
Absorbable hemostatic particles
medafor.comMinneapolis, United States1999Aug 2013$200M
Inflatable medical devices for aortic valvuloplasty
lomavistamedical.comBurlingame, United States2007Jul 2013$32.5M
Provider of air leak sealant for thoracic surgery
neomend.comIrvine, United States1999Oct 2012$140M
Drug-coated balloon catheters are developed for vascular lesion treatments.
lutonix.comMinneapolis, United States2007Dec 2011$225M
Premium access

Complete acquisition details for CR Bard

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of CR Bard

13 dated milestones of CR Bard across 113 years, from founding to its latest funding, stage changes and deals.

  1. Founded CR Bard is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Lutonix.
  4. Acquisition Acquires Neomend.
  5. Acquisition Acquires Lomavistamedical.
  6. Acquisition Acquires Medafor.
  7. Acquisition Acquires Rochester Medical Corporation.
  8. Acquisition Acquires Vascular Pathways.
  9. Acquisition Acquires Liberator Medical Supply.
  10. Acquisition Acquires Embo Medical.
  11. Exit Acquired by Becton Dickinson.
  12. Acquisition Acquires PureWick.
  13. Acquisition Acquires LifeBond.

Web traffic of CR Bard

Websites that share an audience with CR Bard (crbard.com).

Similar websites

Websites whose visitors overlap most with CR Bard. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
covidien.com
100%
––View details
sjm.com
92%
1.2K#13,629,967View details
medtronic.com
89%
2.6M#22,622View details
bardmedical.com
bardmedical.com
87%
–––
bostonscientific.com
86%
738.5K#88,615View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 19 similar websites and full traffic analytics for CR Bard

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 19 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Cr Bard

Premium access

Complete news archive for CR Bard

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to CR Bard

10 companies that operate in the same segment as CR Bard (Diversified Medical Devices), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical equipment for treating over 30 chronic diseases is developed.
1949Minneapolis, Minnesota, United States–USD 36.36 B95,000
Wide range of medical devices
1979Marlborough, Massachusetts, United States–USD 20.07 B53,000
Healthcare solutions are provided by Johnson & Johnson globally.
1886New Brunswick, New Jersey, United States–USD 94.18 B139,800
Diagnostic and surgical products for women's healthcare are provided.
1985Marlborough, Massachusetts, United States–USD 4.1 B7,060
Developer of drug candidates for the treatment of rare CNS disorders
1971Boston, Massachusetts, United StatesUSD 105.8 M–487
Surgical instruments are manufactured for multiple therapeutic areas.
1987Utica, New York, United States–USD 1.37 B3,900
A wide range of medical devices is developed by HOYA.
1941Tokyo, Tokyo, Japan–USD 5.94 B37,910
Medical devices for cardiac and neuromodulation therapies are manufactured globally.
1976Saint Paul, Minnesota, United States–––
Complex healthcare challenges are addressed through technology solutions by Commure.
2016San Francisco, California, United StatesUSD 823.3 M–316
Provider of medical devices for emergency medicine and various health conditions
1943Wayne, United States–USD 1.99 B14,100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about CR Bard

CR Bard was founded in 1907.

CR Bard is headquartered in Murray, United States. It is registered at Murray, Kentucky, United States.

CR Bard has 125 employees.

The primary company behind CR Bard, Bard India Healthcare Private Limited, reported revenue of ₹264 Cr for FY 2023, up 32% year on year.

C. R. Bard, Inc., now branded simply as Bard, is a leading multinational developer, manufacturer, and marketer of medical technologies in the fields of vascular, urology, oncology, and surgical specialties. Bard markets its products and services worldwide to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. A company with approximately 14,000 employees, Bard is perhaps best known for having introduced the Foley catheter. Bard began negotiations to settle nearly 30,000 legal claims related to implantable vaginal meshes made by the company.

CR Bard has made 17 acquisitions, including Amertek Medical, Angiomed, and ClearStream.

CR Bard has 1 investor. Key investors include BD.

CR Bard operates through Bard India Healthcare Private Limited.

Yes. CR Bard was acquired by Becton Dickinson in April 2017.

The legal entities of CR Bard currently have 4 directors, including Puay Lian Geraldine Lim, Deepak Malhotra, Ulrich Stefer and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available